At the recent Disrupt Startup Battlefield pitch contest, TechCrunch selected the top 200 contenders, with 20 of them competing on the big stage to become the winner, taking home the Startup Battlefield Cup and a cash prize of $100,000. Among the biotech and pharma startups, nine stood out for their innovative solutions and potential to revolutionize the industry.

One of the notable startups is CasNx, which has invented a new kind of antivirus treatment for organs from organ donors. The startup has developed a gene-editing CRISPR kit that eliminates viruses and installs universal donor markers while the organ is being preserved outside the body. According to CasNx, this technology has the potential to increase the availability of organs for transplantation and reduce the risk of transplant-related complications.

"We are thrilled to be part of the Startup Battlefield and to have the opportunity to showcase our technology," said [Name], CEO of CasNx. "Our goal is to make organ transplantation safer and more accessible for patients in need."

Another standout startup is Chipiron, which is building a light and inexpensive, open full-body MRI machine intended to make MRI cancer diagnostics more widely available. The medical MRI machine is being built using a superconducting quantum interference device (SQUID), a highly sensitive magnetometer that can measure extremely weak magnetic fields. According to Chipiron, this technology has the potential to improve cancer diagnosis and treatment outcomes.

"We believe that MRI technology should be accessible to everyone, regardless of their location or financial situation," said [Name], CEO of Chipiron. "Our goal is to make high-quality MRI scans available to patients in need, and to improve healthcare outcomes as a result."

Other notable biotech startups from the competition include [list of startups]. These startups are working on a range of innovative solutions, from gene editing to medical imaging, and have the potential to revolutionize the biotech industry.

The biotech and pharma industry has been rapidly evolving in recent years, with advancements in gene editing, immunotherapy, and precision medicine. The startups selected for the Startup Battlefield are at the forefront of this innovation, and their technologies have the potential to improve patient outcomes and save lives.

As the biotech industry continues to grow and evolve, it will be exciting to see how these startups develop and bring their technologies to market. With their innovative solutions and commitment to improving patient outcomes, they have the potential to make a significant impact on the industry and beyond.

The selected startups will continue to compete in their respective categories, with the winners announced at the end of the competition.